Compile Data Set for Download or QSAR
Report error Found 10 Enz. Inhib. hit(s) with all data for entry = 10544
TargetAndrogen receptor(Human)
Glaxosmithkline Intellectual Property (No. 2)

US Patent
LigandPNGBDBM332408(US10196353, Example 52 | US11299457, Example 52)
Affinity DataIC50: 15.8nMAssay Description:The androgen receptor fluorescence polarization assay is used to investigate the interaction of the compounds with the androgen receptor.Compounds ar...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Glaxosmithkline Intellectual Property (No. 2)

US Patent
LigandPNGBDBM332406(US10196353, Example 32 | US11299457, Example 32)
Affinity DataIC50: 31.6nMAssay Description:The androgen receptor fluorescence polarization assay is used to investigate the interaction of the compounds with the androgen receptor.Compounds ar...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Glaxosmithkline Intellectual Property (No. 2)

US Patent
LigandPNGBDBM332402(US10196353, Example 17 | US11299457, Example 17)
Affinity DataIC50: 79.4nMAssay Description:The androgen receptor fluorescence polarization assay is used to investigate the interaction of the compounds with the androgen receptor.Compounds ar...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Glaxosmithkline Intellectual Property (No. 2)

US Patent
LigandPNGBDBM332405(US10196353, Example 27 | US11299457, Example 27)
Affinity DataIC50: 79.4nMAssay Description:The androgen receptor fluorescence polarization assay is used to investigate the interaction of the compounds with the androgen receptor.Compounds ar...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Glaxosmithkline Intellectual Property (No. 2)

US Patent
LigandPNGBDBM332052(US10196353, Example 2 | US11299457, Example 2)
Affinity DataIC50: 100nMAssay Description:The androgen receptor fluorescence polarization assay is used to investigate the interaction of the compounds with the androgen receptor.Compounds ar...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Glaxosmithkline Intellectual Property (No. 2)

US Patent
LigandPNGBDBM332404(US10196353, Example 22 | US11299457, Example 22)
Affinity DataIC50: 158nMAssay Description:The androgen receptor fluorescence polarization assay is used to investigate the interaction of the compounds with the androgen receptor.Compounds ar...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Glaxosmithkline Intellectual Property (No. 2)

US Patent
LigandPNGBDBM332401(US10196353, Example 12 | US11299457, Example 12)
Affinity DataIC50: 251nMAssay Description:The androgen receptor fluorescence polarization assay is used to investigate the interaction of the compounds with the androgen receptor.Compounds ar...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Glaxosmithkline Intellectual Property (No. 2)

US Patent
LigandPNGBDBM332403(US10196353, Example 21 | US11299457, Example 21)
Affinity DataIC50: 316nMAssay Description:The androgen receptor fluorescence polarization assay is used to investigate the interaction of the compounds with the androgen receptor.Compounds ar...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Glaxosmithkline Intellectual Property (No. 2)

US Patent
LigandPNGBDBM332400(US10196353, Example 7 | US11299457, Example 7)
Affinity DataIC50: 631nMAssay Description:The androgen receptor fluorescence polarization assay is used to investigate the interaction of the compounds with the androgen receptor.Compounds ar...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Glaxosmithkline Intellectual Property (No. 2)

US Patent
LigandPNGBDBM332407(US10196353, Example 43 | US11299457, Example 43)
Affinity DataIC50: 631nMAssay Description:The androgen receptor fluorescence polarization assay is used to investigate the interaction of the compounds with the androgen receptor.Compounds ar...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2022
Entry Details
Go to US Patent